How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

229 results for

Microdermabrasion

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Adapalene 0.3%

acne treatments (2 weeks); Retinoids (4 weeks); Cosmetic/aesthetic procedures on the face (1 week); Photodynamic therapy, laser therapy, microdermabrasion for acne (3 months) Subject having received at least one of the following systemic treatments: Corticosteroids (except locally acting corticosteroids such as inhaled or intrathecal or dermal application at distance from the face), antibiotics (except penicillin) (1 month); Spironolactone (3 months) / Drospirenone (3 months, unless dose is stable

2016 Clinical Trials

62. Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products

with error rate < 1 %/year no sex vasectomy of the partner Diseases of the facial skin other than acne No concomitant topical medications (including make-up) or keratolytics as sulphur, salicylic acid, benzoyl peroxide, resorcin and abradents and acid-containing peels one week before the study starts Patients who had facial procedures (chemical peel, laser therapy, photodynamic therapy, microdermabrasion, or UV light therapy) within the past 4 weeks No concomitant participation in other studies within

2016 Clinical Trials

63. Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris

. Cosmetic facial procedures (chemical or laser peel, microdermabrasion, etc.) within the 28 days of the first dose or during the study. History of sensitivity to any of the study medications, or components thereof or a history of drug or other allergy that, in the opinion of the Investigator or Medical Monitor, contraindicates their participation. Any condition that the study Investigator feels would indicate that participation would not be in the best interest of the participant. The participant has

2016 Clinical Trials

64. Clinical Endpoint Study of Ivermectin 1% Cream

the study. Use within 1 month prior to baseline of 1) topical retinoids to the face, 2) systemic (e.g., oral or injectable) antibiotics known to have an impact on the severity of facial rosacea (e.g., containing tetracycline and its derivatives, erythromycin and its derivatives, sulfamethoxazole, or trimethoprim), 3) systemic steroids, 4) photodynamic therapy (including laser and other light therapies), or 6) cosmetic procedures (e.g., superficial chemical peels, exfoliation or microdermabrasion

2016 Clinical Trials

65. A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines

topical products containing alpha-hydroxy acids, salicylic acid, and vitamins C or D (includes derivatives thereof) on the perioral areas within 7 days prior to or during the study period, other than the study products A patient receiving any investigational drug and/or has had a microdermabrasion (light or medium skin peel) treatment on their perioral areas within 30 days prior to or during the study period A patient using any topical tretinoin product or derivative on their perioral areas within 12

2016 Clinical Trials

66. BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris

, laser, microdermabrasion) within 8 weeks of baseline (Day 0). Have excessive sun exposure, is planning a trip to a sunny climate or used tanning booths within 28 days prior to baseline (Day 0) or is not willing to minimize natural and artificial sunlight exposure during the study. Have received photodynamic therapy or phototherapy with blue or red light within 12 weeks of baseline (Day 0). Have used androgen receptor blockers (such as spironolactone or flutamide) within 12 weeks of baseline (Day 0

2016 Clinical Trials

67. Timolol for the Treatment of Acne and Rosacea

) for 4 weeks Photodynamic therapy , laser therapy or microdermabrasion for 4 weeks Other topicals or oral acne medications such as antibiotics within 3 weeks o Biopsy volunteer specific exclusion criteria: History of keloids History of hypertrophic scars Allergy to lidocaine or epinephrine Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided

2016 Clinical Trials

68. Literature Review of Cosmetic Procedures in Men: Approaches and Techniques are Gender Specific. (Abstract)

dermatologic procedures pursued by men by conducting a comprehensive literature review pertaining to non-surgical cosmetic procedures in male patients. The most common and rapidly expanding non-surgical interventions in men include botulinum toxin, filler injection, chemical peels, microdermabrasion, laser resurfacing, laser hair removal, hair transplantation, and minimally invasive techniques for adipose tissue reduction. Important sex-specific factors associated with each of these procedures should

2016 American journal of clinical dermatology

69. Gene Expression Following Ultherapy® Treatment

that may affect wound healing. Severe solar elastosis. Significant scarring in the area(s) to be treated that would interfere with assessing results. Open wounds or lesions in the area(s) to be treated. Severe or cystic acne on the area(s) to be treated. Active implants (e.g., pacemakers or defibrillators), or metallic implants in the treatment areas (dental implants not included.) Inability to understand the protocol or to give informed consent. Microdermabrasion, or prescription level glycolic acid

2015 Clinical Trials

70. Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With Photodamage

products may be used. Subjects who have used anti-aging skincare products (cosmetic and drug products with any of the following ingredients: AHA, Salicylic Acid, Vitamins A, Retin-A, Vitamin C, Growth Factors or Peptides, Antioxidants such as Idebenone, CoffeeBerry, CE Ferulic, Phloretin, etc.) within the last 3 months and during the course of the study. Subjects with recent history in the past 6 months and during the course of the study of laser, chemical peels, microdermabrasion, or other medical

2015 Clinical Trials

71. Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers

. Excessive skin laxity on the area(s) to be treated. Significant scarring in the area(s) to be treated. Open wounds or lesions in the area(s) to be treated. Severe or cystic acne on the area(s) to be treated. Active implants (e.g., pacemakers or defibrillators), or metallic implants in the treatment areas (dental implants not included). Inability to understand the protocol or to give informed consent. Microdermabrasion, or prescription level glycolic acid treatment to the treatment area(s) within two

2015 Clinical Trials

72. A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

units/day within 6 months of Baseline. Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the past 8 weeks or during the study. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02431052 Sponsors and Collaborators Dermira, Inc

2015 Clinical Trials

73. A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

or other investigational research study History of non-compliance with clinical research protocols Ablative laser resurfacing to on their face within 12 months Non-ablative laser or light procedures to their face within the past 3 months Microdermabrasion (light or medium skin peel) treatment on their face within the past 30 days Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using

2015 Clinical Trials

74. A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris

8 weeks (56 days) prior to Baseline and throughout the study: - Facial procedures (chemical or laser peel, microdermabrasion, etc.); Within 4 weeks (28 days) prior to Baseline and throughout the study: Treatment with systemic corticosteroids (including intranasal and inhaled corticosteroids); Treatment with systemic antibiotics or systemic anti-acne drugs or systemic anti-inflammatory drugs; Note: Non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin use on an as-needed basis

2015 Clinical Trials

75. Effect of Carbon Dioxide Facial Therapy on Skin Oxygenation. (Abstract)

suited for full-face treatment has been developed, though its efficacy in oxygenating the skin has not been thoroughly investigated.The aim of this study was to evaluate the ability of the CO2 facial to oxygenate the skin.Twelve patients were enrolled in this split-face study. They were treated one week apart with a CO2 facial on one side of the face and particle-free microdermabrasion on the other. Measurements of transcutaneous oxygen tension (tcPO2) were recorded at baseline and after each (...) treatment. Statistical significance was assessed by comparing the average tcPO2 difference in mmHg following microdermabrasion and after a carbon dioxide facial using a 1-tailed paired t-test (α = 0.05).
The average increase in tcPO2 after CO2 facial treatment was statistically significantly greater (p = .0252) than after microdermabrasion.Carbon dioxide facials improve skin oxygenation immediately following treatment, attributable to the generation of an artificial Bohr effect.

2015 Journal of drugs in dermatology : JDD Controlled trial quality: uncertain

76. Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

or Cryotherapy within 2 weeks of initiation of treatment Retinoids, including tazarotene, adapalene, tretinoin, within 4 weeks Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5 fluorouracil, diclofenac, ingenol mebutate, imiquimod or other topical treatments for AK within 8 weeks use of systemic retinoid therapy within 6 months Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research

2015 Clinical Trials

77. Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

of treatment Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-FU, diclofenac, imiquimod or other topical treatments for AK within 8 weeks of initiation of treatment use of systemic retinoid therapy within 6 months of initiation of treatment Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer

2015 Clinical Trials

78. 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne

, or breast feeding. Has an active or chronic skin allergy. Has a history of acute or chronic disease that might interfere with or increase the risk of study participation. Had skin cancer treatment in preceding 12 months. Has damaged skin on facial areas (eg, sunburn, tattoo, or scar) Had any medical procedure (eg, laser resurfacing, chemical peel, or plastic surgery) on facial areas in preceding 12 months. Had any cosmetic procedure (eg, microdermabrasion) on facial areas within 8 weeks of the baseline

2015 Clinical Trials

79. Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times

Microdermabrasion, laser ablative treatments or chemical peels within 8 weeks of the initiation of treatment. 5-FU, imiquimod or ALA-PDT within 6 months of initiation of treatment. Subject has used any of the following systemic medications: Immuno-suppressants including steroids, chemotherapy, etc. within 3 months of the initiation of treatment Retinoid therapy within 6 months of the initiation of treatment. Contacts and Locations Go to Information from the National Library of Medicine To learn more about

2015 Clinical Trials

80. Evaluation of the KLOX BioPhotonic WoundGel System in the Treatment of Surgical Wounds

with severe elastosis Patients with severe or cystic acne on the area(s) to be treated Presence of a metal stent or implant in the area(s) to be treated Patients with derma resurfacing procedures or non-invasive skin-tightening procedures including medium/deep chemical peeling, microdermabrasion, laser therapy or prescription level glycolic acid treatment to the treatment area(s) within three months prior to Study Screening or during the Study Patients anticipating the need for surgery or overnight

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>